Sirolimus rescue treatment in calcineurin-inhibitor nephrotoxicity after kidney transplantation.
Wyzgal
J
J
Institute of Transplantology, Medical University of Warsaw, Warsaw, Poland. gsenat@amwaw.edu.pl
Paczek
L
L
Senatorski
G
G
Zygier
J
J
Rowiński
W
W
Szmidt
J
J
Perkowska
A
A
D065095:Calcineurin Inhibitors; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use* / Q000633:toxicity; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D020123:Sirolimus / Q000627:therapeutic use* / Q000633:toxicity; D018709:Statistics, Nonparametric
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D020123:Sirolimus